Journal articleCancer Biol Ther2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress.
- Journal
- Cancer Biol Ther
- Published
- 8 November 2024
- Citations
- 9
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try
Grants 7
- The Role of post-translational activation of Myc in pancreatic cancer R01CA196228↗
- Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer R01CA212600↗
- Optimizing anti-wild-type IDH1 therapy in pancreatic cancer R01CA287672↗
- Developing a patient derived model platform to treat BRCA1/2-mutant pancreatic cancers R21CA263996↗
- Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer U01CA217842↗
- Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens U01CA224012↗
- Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified commun… U01CA278923↗